ID
12248
Description
An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). NCT00090051 BO17072
Keywords
Versions (2)
- 10/1/15 10/1/15 -
- 10/28/15 10/28/15 -
Uploaded on
October 28, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
CLL Follow-Up BO17072 NCT00090051
Follow-Up Study completion Chronic Lymphocytic Leukemia BO17072 NCT00090051
Description
Bone marrow sampling for molecular response
Description
Date of 1st confirmation (Sample number 501)
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C1611825
Description
Remarks of 1st confirmation (Sample number 501)
Data type
text
Alias
- UMLS CUI [1]
- C0282411
Description
Date of 2nd Confirmation (Sample number 502)
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C0750484
Description
Remarks of 2nd confirmation (Sample number 502)
Data type
text
Alias
- UMLS CUI [1]
- C0282411
Description
Blood sampling for molecular response
Description
Date of 1st confirmation (Sample number 601)
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C1611825
Description
Remarks of 1st confirmation (Sample number 601)
Data type
text
Alias
- UMLS CUI [1]
- C0282411
Description
Date of 2nd confirmation (Sample number 602)
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C0750484
Description
Remarks of 2nd confirmation (Sample number 602)
Data type
text
Alias
- UMLS CUI [1]
- C0282411
Description
Completion of follow-up period
Description
Study completion
Description
Date of last contact
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C0805839
Description
Study completion
Data type
boolean
Alias
- UMLS CUI [1]
- C3274569
Description
Reason for no completion
Data type
integer
Alias
- UMLS CUI [1]
- C1709849
Description
Specify violation of selection criteria
Data type
text
Alias
- UMLS CUI [1]
- C0242801
Description
Specify other protocol violation
Data type
text
Alias
- UMLS CUI [1]
- C1709750
Description
Specify other reason
Data type
text
Alias
- UMLS CUI [1]
- C3840932
Description
Survival visit
Description
Date of contact
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C0805839
Description
Survival status
Data type
integer
Alias
- UMLS CUI [1]
- C0220921
Description
Date of Death
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C1148348
Description
Date of last contact
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C0805839
Description
Cause of death
Data type
integer
Alias
- UMLS CUI [1]
- C0007465
Description
Specify other cause of death
Data type
text
Alias
- UMLS CUI [1]
- C0007465
Description
Disease progression
Data type
integer
Alias
- UMLS CUI [1]
- C0242656
Description
Date of progressive disease
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C0011008